Precision medicines for paediatric acute myeloid leukaemia
Finding which MEK inhibitors work best for children with acute myeloid leukaemia.
We have been funding expert research since 2016, aiming to ensure that every child and young person has a safe and effective treatment for their cancer, and that they can live long and happy lives post-treatment.
Finding which MEK inhibitors work best for children with acute myeloid leukaemia.
Finding why immunotherapy doesn't work for some children with sarcoma tumours.
Testing nanoparticles as a way of getting drugs where they are needed for acute myeloid leukaemia.
Looking at molecular makeup and MRIs to characterise infant ependymoma.
Assessing whether blocking a protein's activity could improve survival and reduce side effects.
Understanding how proteins act inside acute myeloid leukaemia cells, to find new drug targets.
Creating antibodies in the lab to treat diffuse midline gliomas and testing their effectiveness.
Stopping protein activity to stop anaplastic large cell lymphomas from growing.
Helping children in sub-Saharan Africa with endemic Burkitt Lymphoma get diagnosed earlier.